1. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases;Scientific Reports;2024-02-19
2. Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis;Rational Pharmacotherapy in Cardiology;2024-02-01
3. The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation;Human Genomics;2023-07-07
4. Thromboembolism in Older Adults;Frontiers in Medicine;2021-01-27
5. The effect of warfarin, heparin, and modern directly acting oral anticoagulants (dabigatran etexilate, rivaroxaban, apixaban) on the level of coagulation factors: V, VII, VIII, IX, XII, WF;HERALD of North-Western State Medical University named after I.I. Mechnikov;2019-04-25